Publicacions en col·laboració amb investigadors/es de Hospital Universitario 12 de Octubre (100)

2024

  1. Erratum: Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome medicine (2023) 15 1 (22))

    Genome medicine

  2. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells

    Science Immunology, Vol. 9, Núm. 91

  3. The lack of either IRF9, or STAT2, has surprisingly little effect on human natural killer cell development and function

    Immunology, Vol. 172, Núm. 3, pp. 440-450

2023

  1. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

  2. Hemodialysis-Associated Immune Dysregulation in SARS-CoV-2-Infected End-Stage Renal Disease Patients

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  3. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome

    Journal of Allergy and Clinical Immunology, Vol. 151, Núm. 4, pp. 1081-1095

  4. Novel Germline TET2 Mutations in Two Unrelated Patients with Autoimmune Lymphoproliferative Syndrome-Like Phenotype and Hematologic Malignancy

    Journal of Clinical Immunology, Vol. 43, Núm. 1, pp. 165-180

  5. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

  6. TCF3 haploinsufficiency defined by immune, clinical, gene-dosage, and murine studies

    Journal of Allergy and Clinical Immunology, Vol. 152, Núm. 3, pp. 736-747

2022

  1. An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution

    Biomedicines, Vol. 10, Núm. 2

  2. Eczematous dermatitis and thrombocytopenia in a 10-month-old boy

    JEADV Clinical Practice, Vol. 1, Núm. 1, pp. 62-65

  3. Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

  4. Human genetic and immunological determinants of critical COVID-19 pneumonia

    Nature, Vol. 603, Núm. 7902, pp. 587-598

  5. Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency

    Journal of Clinical Immunology, Vol. 42, Núm. 2, pp. 240-252

2021

  1. Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma

    Turkish journal of haematology : official journal of Turkish Society of Haematology, Vol. 38, Núm. 2, pp. 145-150

  2. Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019

    ACR Open Rheumatology, Vol. 3, Núm. 4, pp. 267-276

  3. Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS)

    Critical Reviews in Clinical Laboratory Sciences, Vol. 58, Núm. 4, pp. 253-274

  4. Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination

    PLoS Pathogens, Vol. 17, Núm. 12

  5. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management

    Frontiers in Immunology, Vol. 12

  6. T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression

    Frontiers in Cellular and Infection Microbiology, Vol. 11